As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Power Queen, the leader in lithium battery technology, introduces its latest innovation: the 12V 280Ah Low Temperature Deep ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

As the Christmas bells draw near, Hinen Australia today announced the launch of its highly anticipated Christmas promotion, ...

The US FDA has cleared the first-in-class tyrosine kinase 2 (Tyk2) inhibitor as Sotyktu, and BMS says it now plans to launch the new drug later this month, aiming to mount a challenge to Amgen's $ ...

The deal – which is worth up to $905 million with an upfront fee of $90 million – gives BMS full control of BridgeBio's experimental SHP2 inhibitor BBP-398, which is already in a phase 1 trial ...

November 2024 at the St. Regis Saadiyat Island Resort, Abu Dhabi, SIBEC 2024 is set to draw hundreds of fire and life safety ...

BMS clocked $224 million in worldwide sales for the cell therapy in the third quarter, more than double Q3 2023 thanks to its new leukemia indication as well as mantle cell lymphoma, for which the ...

Having built up a stellar reputation for over 45 years in the Mechanical and Electrical Contracting sector throughout Ireland ...

BLUETTI, a leader in portable power stations and eco-friendly energy solutions, launches the Elite 200 V2, a 2KWh ...

BLUETTI, a leader in portable power stations and eco-friendly energy solutions, launches the Elite 200 V2, a 2KWh ...